Notably, experimental evidence supports this hypothesis: insulin has been shown to promote hepatocellular proliferation through IGF‐1 receptor activation and may accelerate progression from steatohepatitis to HCC [23, 25]. The gene discussed is INS; the disease is hepatocellular carcinoma.